India is poised to be a $10 trillion economy by 2030. There also exist opportunities to enable and empower industries that have…
ChemRobotics Pvt. Ltd. © 2023, All Rights Reserved.
Designed and Developed by Ample eBusiness
Tag:
treatment
-
-
Cipla healthcare has launched Naselin antiviral nasal spray with Povidone Iodine that can offer the first line of defence against the COVID-causing…
-
CompaniesMerck & Co
Merck’s Keytruda Gets EU Approval for Treatment of Triple-Negative Breast Cancer.
by adminby adminThe European Commission has cleared Keytruda (Pembrolizumab) in combination with chemotherapy as a first-line treatment for locally recurrent, unresectable or metastatic TNBC…
-
AgrochemicalsMefenoxam
Albaugh’s Anchor 3L ST (Metalaxyl-M) Fungicide Seed Treatment Launched in US Seed Treatment Market.
by adminby adminKeypoints Albaugh announced the EPA registration of Anchor™ 3L ST in multiple crop segments as a new fungicide seed treatment offer. Anchor™…
-
Active Pharmaceutical Ingredients (API)BictegravirEmtricitabineTenofovir Alafenamide
USFDA Approves Expanded Indication of Gilead’s Biktarvy for Treatment of HIV-1 in Pediatric Populations
by adminby adminKeypoints FDA Approves Low-Dose Tablet for HIV Treatment in Virologically Suppressed Children Weighing at Least 14 kg. Biktarvy Provides an Effective Treatment…
-
Active Pharmaceutical Ingredients (API)Chugai Pharmaceuticals and Oncolys BioPhamaCompaniesTelomelysin
Oncolys BioPharma and Chugai Pharmaceuticals agree to Terminate Exclusive License Agreement on Oncolytic Viral Immunotherapy, OBP-301(Telomelysin)
by adminby adminKeypoints: Chugai, Oncolys BioPharma agree to terminate exclusive license agreement on oncolytic viral immunotherapy, OBP-301 The effective date of the termination will…
-
Active Agrochemical IngredientAtezolizumab
USFDA approves Roche’s Tecentriq (Atezolizumab) as Adjuvant Treatment for Non- small Cell Lung Cancer.
by adminby adminKeypoints USFDA approves Roche’s Tecentriq as adjuvant treatment for certain people with early NSCLC Tecentriq treatment reduced the risk of disease recurrence…
-
AbemaciclibActive Pharmaceutical Ingredients (API)
Agilent Technologies’ Ki-67 IHC MIB-1 PharmDx assay has been approved by the FDA for use as a Companion Diagnostic to Eli Lilly’s Abemaciclib, or Verzenio.
by adminby adminKEYPOINTS The FDA has given the Ki-67 IHC MIB-1 pharmDx assay a companion diagnostic approval for detecting Ki-67 expression in patients with…
Older Posts